Carve-Out Acquisitions: The Execution Playbook | LeverVenture

A carve-out is not a smaller version of a normal acquisition. It is the purchase of a company that does not yet exist. The division being sold has a product, a customer base, and a team, but it has never once run its own payroll, negotiated its own vendor contracts, or reported its own financials without a parent's shared-services stack underneath it. Everything that made the business look like a company on the data room slides was, until closing, borrowed.

That is why carve-outs price at a discount to comparable standalone targets, and why the discount is not free money. It is compensation for a specific, front-loaded body of work: separating a functioning business from the infrastructure it grew up inside of, on a clock the buyer does not fully control. Investors who treat the discount as margin rather than a budget for that work are the ones who overpay.

This is true across industries, but it is sharper in life sciences and healthcare, where a carved-out diagnostics or device division often carries regulatory registrations, quality systems, and payer contracts that are legally and operationally entangled with the parent in ways a generic industrial carve-out is not. Untangling a 510(k) holder or a CLIA-certified lab from the entity that has held its licenses for a decade is not a line item. It is a workstream with its own critical path.

01What the discount actually pays for

Three things drive carve-out pricing below comparable standalone multiples, and a buyer underwriting one should be able to name all three before signing, not discover them after.

The first is execution risk that a normal acquisition does not carry: the buyer is underwriting a management team, systems, and cost structure that will exist in the future, not the ones in the data room today. The second is stranded cost — corporate overhead the parent will stop absorbing at close, some of which the new standalone entity must replace and some of which simply disappears with no replacement plan in place unless someone builds one. The third is time value: a carve-out typically takes longer to reach full run-rate performance than an acquisition of an already-standalone company, and that delay has a cost that belongs in the model, not in a footnote.

The mistake is treating the multiple discount as the reward and skipping past the fact that it is also the price of admission to a harder operating problem. A buyer who models the discount but not the separation cost has, in effect, bought the company twice — once at close, and once again in the unbudgeted work of the first year.

02The transition services agreement is a lease on someone else's patience

Every carve-out closes with a transition services agreement, and every TSA is, functionally, a lease. The seller keeps running payroll, IT, and finance for the newly separated business for a defined period, usually measured in months, at a price that is rarely cheap and never permanent. The TSA is not a safety net. It is a countdown, and the terms of its expiration deserve more diligence than they typically get.

The failure mode is well known and still common: a buyer treats the TSA period as time to focus on growth, defers building the standalone finance or IT function until the TSA is most of the way through its term, and then discovers that hiring a controller, licensing an ERP instance, and migrating payroll cannot be compressed into the final ninety days without real operational risk. The parent has no incentive to extend past the negotiated term on favorable pricing — the whole point of the TSA, from the seller's side, is to stop touching the business it sold.

The workstreams inside a TSA are not uniform in difficulty, and a buyer should price them accordingly rather than treating "we have a TSA" as one undifferentiated comfort blanket.

The right posture is to start standing up the permanent function on day one, use the TSA as a backstop rather than a plan, and renegotiate service-level detail before signing rather than after a problem surfaces. A TSA renegotiated under duress, six weeks before expiration, is a weak negotiating position no buyer should choose to be in.

03Untangling what was never really separate

Shared contracts and shared intellectual property are where a carve-out's legal complexity concentrates, and where the gap between "signed" and "separated" tends to be widest. A parent's master service agreements with vendors, its enterprise software licenses, its group insurance programs, and often its patent and trademark portfolios were negotiated for the whole company, not for the division being sold. Consent to assign is not guaranteed, and a vendor who knows a change of control is happening has real leverage to reprice.

Intellectual property carries a version of the same problem with higher stakes in a life sciences context. A diagnostics or device division may have contributed to patents filed under the parent's name, used platform technology the parent continues to hold, or relied on regulatory submissions that list the parent as the applicant of record. Separating what belongs to the divested business from what the parent retains — and licensing back what must be shared going forward — is diligence work that determines what the buyer actually owns, not just what it paid for.

The purchase agreement transfers ownership on a single date. Operational independence arrives on its own schedule, and the gap between the two is where carve-outs succeed or fail.

04The first hundred days

The standard advice to build a hundred-day plan applies to every acquisition, but a carve-out's hundred-day plan carries a different mandate: it is not primarily about growth initiatives, it is about proving the business can function as a company. Can it close its own books. Can it run payroll without the parent's system. Can it renew a customer contract that named the parent as counterparty. These are not exciting questions, and they are the ones that determine whether everything else is possible.

A useful discipline is separating the hundred-day plan into what must be true for the business to survive independently and what would be nice for it to achieve while doing so. Stranded-cost remediation, TSA exit readiness, and standalone financial controls belong in the first category. Go-to-market expansion, new hires beyond what separation requires, and platform investment belong in the second. Conflating the two is how a carve-out's first year gets consumed by growth ambitions that a business which cannot yet close its own books was never ready to pursue.

05What this means for underwriting

A carve-out should be modeled as two overlapping projects: the business as it will eventually run standalone, and the separation program required to get it there, with its own budget, timeline, and named owner. The discount in the purchase price is not profit to be banked at close; it is the funding source for that second project, and it should be sized against a realistic estimate of stranded cost and TSA exit spending rather than against optimism about how quickly a lean team can stand up a finance function from scratch.

The businesses that clear this bar well are the ones whose management team, incoming or retained, has actually run a standalone company before — not merely operated a division inside one. That experience is difficult to underwrite from a resume alone, but it is worth weighting as heavily as any financial metric in the data room, because the hundred-day plan lives or dies on judgment calls that no model anticipates. Investors evaluating a carve-out should treat the separation plan itself, not just the projected P&L, as the primary underwriting document.

See also our analysis of where middle-market inefficiency actually lives and the related question of when a platform should build versus buy.

Nothing in this piece is investment, legal, tax or accounting advice, and nothing in it is an offer to sell or a solicitation of an offer to buy any security.